NCT02671435 2025-07-22A Study of Durvalumab (MEDI4736) and Monalizumab in Solid TumorsMedImmune LLCPhase 1/2 Active not recruiting383 enrolled 48 charts
NCT03833440 2024-05-03PIONeeRAssistance Publique Hopitaux De MarseillePhase 2 Active not recruiting114 enrolled